HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kouji Yamaguchi Selected Research

Drug Substitution

5/2010Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
5/2009Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kouji Yamaguchi Research Topics

Disease

3Osteonecrosis (Kienbock's Disease)
05/2010 - 05/2009
3Necrosis
05/2010 - 01/2003
3Neoplasms (Cancer)
10/2007 - 10/2002
2Osteoporosis
01/2013 - 04/2010
2Hepatitis
09/2011 - 08/2009
2Inflammation
05/2010 - 05/2009
2Stomach Neoplasms (Stomach Cancer)
10/2007 - 09/2007
2Shock
03/2006 - 11/2002
1Bone Resorption
01/2013
1Peritonitis
09/2007
1Splenomegaly
02/2007
1Chronic Hepatitis (Chronic Active Hepatitis)
10/2006
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2006
1Anaphylaxis (Anaphylactic Shock)
03/2006
1Carcinoma (Carcinomatosis)
02/2005
1Adenocarcinoma
02/2005
1Pathologic Constriction (Stenosis)
01/2005
1Hepatocellular Carcinoma (Hepatoma)
10/2002

Drug/Important Bio-Agent (IBA)

2DiphosphonatesIBA
01/2013 - 04/2010
2Serotonin (5 Hydroxytryptamine)IBA
09/2011 - 03/2006
2TransaminasesIBA
09/2011 - 08/2009
2Durapatite (Hydroxylapatite)IBA
05/2010 - 05/2009
2zoledronic acid (zoledronate)FDA Link
05/2010 - 05/2009
2Etidronic Acid (HEDP)FDA LinkGeneric
05/2010 - 04/2010
2Interleukin-1 (Interleukin 1)IBA
08/2009 - 01/2003
2Fluorouracil (Carac)FDA LinkGeneric
09/2007 - 10/2002
2Histidine DecarboxylaseIBA
02/2007 - 01/2003
2Complement System Proteins (Complement)IBA
03/2006 - 11/2002
1YM 529IBA
01/2013
1P-SelectinIBA
09/2011
1Concanavalin AIBA
09/2011
1NitrogenIBA
04/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2009
1CaspasesIBA
08/2009
1Alanine (L-Alanine)FDA Link
08/2009
1AsparagineIBA
08/2009
1Alendronate (Alendronate Sodium)FDA LinkGeneric
05/2009
1Clodronic Acid (Clodronate)IBA
05/2009
1risedronic acid (risedronate)FDA LinkGeneric
05/2009
1pamidronate (APD)FDA LinkGeneric
05/2009
1iodonitrotetrazolium (INT)IBA
10/2007
1Paclitaxel (Taxol)FDA LinkGeneric
09/2007
1Histamine (Histamine Dihydrochloride)FDA Link
02/2007
1Carbon MonoxideIBA
10/2006
1Liposomes (Liposome)IBA
03/2006
1Klebsiella O3 lipopolysaccharideIBA
03/2006
1MucinsIBA
02/2005
1tebufenozide (Mimic)IBA
02/2005
1Rokitansky-Aschoff sinuses of the gallbladderIBA
02/2005
1O Antigens (O Antigen)IBA
11/2002
1acarboxyprothrombin (PIVKA)IBA
10/2002
1Vitamin KFDA Link
10/2002
1Interferon-alpha (Interferon Alfa)FDA Link
10/2002

Therapy/Procedure

2Drug Substitution
05/2010 - 05/2009
2Drug Therapy (Chemotherapy)
10/2007 - 09/2007
1Subcutaneous Injections
05/2009
1Intravenous Injections
03/2006
1Coronary Atherectomy
01/2005
1Hepatectomy
10/2002